Naphtha Supply Disruption Raising Prices of Medical Supplies but Singapore Has Adequate Stockpiles

Why It Matters

Supply‑chain shocks to naphtha could raise medical‑product costs and ripple through multiple plastic‑dependent sectors, testing price stability and resilience.

Key Takeaways

• Middle East conflict disrupts naphtha supply via Strait of Hormuz
• Naphtha price spikes could increase medical product costs up to 50%
• Singapore health ministry assures no shortages, maintains adequate stockpiles
• Manufacturers confront triple threat: energy, logistics, and feedstock disruptions
• Other sectors may feel impact as plastics rely on naphtha

Summary

The video highlights how the ongoing Middle East conflict is choking the flow of naphtha – a crude‑oil by‑product essential for producing the plastics used in syringes, catheters and other disposable medical items. Singapore, which imports much of its feedstock through the Strait of Hormuz, is feeling the ripple effect.

Disruptions in the Hormuz waterway have driven naphtha prices sharply higher, prompting local manufacturers like MetPro Medical Supplies to warn that costs for medical consumables could climb as much as 50%. The sector now faces a “triple threat” of rising energy bills, constrained logistics and scarce feedstock, according to industry insiders.

Health officials stress that public hospitals remain fully stocked, citing diversified sourcing and strategic reserves. Guardian, a major retailer, reports stable pharmacy prices for now, while experts note that alternatives to naphtha exist but lack the scale to offset the shortfall.

While Singapore’s buffer protects patients in the short term, the broader reliance on naphtha means higher input costs will likely filter into consumer‑goods, electronics and other plastic‑intensive industries, pressuring margins and potentially feeding inflation across the region.

Original Description

Naphtha, a key manufacturing component of medical products, is facing unstable supply amid disruptions brought about by the Middle East conflict. Derived from crude oil, the petrochemical liquid mixture is a key ingredient for producing plastics found in syringes and catheters. Suppliers said prices of such medical products are rising and could jump as much as 50%. The Singapore Health Ministry has assured that public healthcare institutions are not facing any shortages and there are adequate stockpiles. Beatrice Yap reports.